CorMedix Stock Price. Everything You Need To Know About The CorMedix Stock!
CorMedix, Inc. is a pharmaceutical and medical device company headquartered in Berkeley Heights, New Jersey. The company, which went public on March 25th, 2010, has been focused on developing and commercializing therapeutic products to combat infectious and inflammatory diseases.
With a team of 40 full-time employees, CorMedix is committed to improving patient outcomes through the development of innovative solutions. The firm’s primary focus is on the development and commercialization of DefenCath, a breakthrough anti-infective solution designed to prevent catheter-related infections and thrombosis in patients requiring central venous catheters for hemodialysis and total parenteral nutrition in clinical settings.
DefenCath is a formulation of taurolidine 13.5 mg/mL and heparin 1000 USP Units/mL that has been gaining traction in Europe and other territories under the brand name Neutrolin. For investors interested in the pharmaceutical industry, CorMedix offers a unique opportunity to support the development of a groundbreaking therapy with the potential to transform patient care.
To make informed investment decisions, it’s important to stay up to date on the latest developments in the stock market, including premarket trends and stock price movements. By regularly researching CorMedix and its competitors, investors can stay informed about industry trends and changes in the stocks share price today. This will help them make informed decisions about buying, holding, or selling shares of this innovative pharmaceutical company.
CorMedix Stock Price. Everything You Need To Know About The CorMedix Stock! performance
- Employees 40
- Company HQ Berkeley Heights
- Website http://www.cormedix.com/
- CRMD Asset Type Common Stock
- CRMD Market Capitalization 293M
- Earnings Per Share -0.91
- Dividends Per Share None
- Dividend Date 2019-03-26
- Quarterly Earnings Growth 0
Are you interested in investing in CorMedix? As an investment platform, Zorion provides users from Malaysia, Thailand, Indonesia, and Vietnam with the opportunity to invest in real US stocks and Pre-IPO companies. CorMedix is a stock worth considering if you’re looking to diversify your investment portfolio. But how can you invest in CorMedix from these countries? Zorion offers investment insights and recommendations, ensuring that retail investors can make informed decisions about their investments. Additionally, Zorion provides resources and educational materials to help investors from Malaysia, Thailand, Indonesia, and Vietnam enhance their investment knowledge. With Zorion’s support, investing in CorMedix can be accessible and profitable for retail investors from these countries.
